GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioject Medical Technologies Inc (OTCPK:BJCT) » Definitions » E10

Bioject Medical Technologies (Bioject Medical Technologies) E10 : $-0.24 (As of Sep. 2011)


View and export this data going back to . Start your Free Trial

What is Bioject Medical Technologies E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bioject Medical Technologies's adjusted earnings per share data for the three months ended in Sep. 2011 was $0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.24 for the trailing ten years ended in Sep. 2011.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-16), Bioject Medical Technologies's current stock price is $0.0001. Bioject Medical Technologies's E10 for the quarter that ended in Sep. 2011 was $-0.24. Bioject Medical Technologies's Shiller PE Ratio of today is .


Bioject Medical Technologies E10 Historical Data

The historical data trend for Bioject Medical Technologies's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioject Medical Technologies E10 Chart

Bioject Medical Technologies Annual Data
Trend Mar01 Mar02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.75 -0.64 -0.54 -0.40 -0.29

Bioject Medical Technologies Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 -0.29 -0.27 -0.25 -0.24

Competitive Comparison of Bioject Medical Technologies's E10

For the Medical Instruments & Supplies subindustry, Bioject Medical Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioject Medical Technologies's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioject Medical Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bioject Medical Technologies's Shiller PE Ratio falls into.



Bioject Medical Technologies E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioject Medical Technologies's adjusted earnings per share data for the three months ended in Sep. 2011 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2011 (Change)*Current CPI (Sep. 2011)
=0.01/95.7269*95.7269
=0.010

Current CPI (Sep. 2011) = 95.7269.

Bioject Medical Technologies Quarterly Data

per share eps CPI Adj_EPS
200112 -0.380 74.552 -0.488
200203 -0.169 75.438 -0.214
200206 -0.170 75.902 -0.214
200209 -0.180 76.366 -0.226
200212 -0.164 76.324 -0.206
200303 -0.210 77.716 -0.259
200306 -0.220 77.505 -0.272
200309 -0.220 78.138 -0.270
200312 -0.216 77.758 -0.266
200403 -0.120 79.066 -0.145
200406 -0.240 80.037 -0.287
200409 -0.160 80.121 -0.191
200412 -0.152 80.290 -0.181
200503 -0.150 81.555 -0.176
200506 -0.090 82.062 -0.105
200509 -0.080 83.876 -0.091
200512 -0.153 83.032 -0.176
200603 -0.180 84.298 -0.204
200606 -0.210 85.606 -0.235
200609 -0.040 85.606 -0.045
200612 -0.080 85.142 -0.090
200703 -0.150 86.640 -0.166
200706 -0.070 87.906 -0.076
200709 -0.050 87.964 -0.054
200712 -0.028 88.616 -0.030
200803 -0.050 90.090 -0.053
200806 -0.060 92.320 -0.062
200809 -0.070 92.307 -0.073
200812 -0.027 88.697 -0.029
200903 -0.010 89.744 -0.011
200906 -0.020 91.003 -0.021
200909 -0.010 91.120 -0.011
200912 -0.023 91.111 -0.024
201003 -0.030 91.821 -0.031
201006 -0.030 91.962 -0.031
201009 -0.020 92.162 -0.021
201012 -0.004 92.474 -0.004
201103 -0.010 94.283 -0.010
201106 0.010 95.235 0.010
201109 0.010 95.727 0.010

Add all the adjusted EPS together and divide 10 will get our e10.


Bioject Medical Technologies  (OTCPK:BJCT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bioject Medical Technologies E10 Related Terms

Thank you for viewing the detailed overview of Bioject Medical Technologies's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioject Medical Technologies (Bioject Medical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
Bioject Medical Technologies Inc commenced operations in 1985 and is a developer and manufacturer of needle-free injection therapy systems (NFITS). The Companys long-term goal is to become supplier of needle-free injection systems to the pharmaceutical and biotechnology industries. It focused its business development efforts on new and existing licensing and supply agreements with pharmaceutical and biotechnology companies, as well as numerous research agreements that could guide to long-term agreements. The Companys pipeline of prospective new partnerships remains active. It is also actively pursuing additional opportunities both domestically and overseas as it expands its current product line. The Companys Biojector 2000 system (B2000) consists of two components: a hand-held, reusable jet injector and a sterile, single-use, disposable plastic syringe capable of delivering variable doses of medication up to 1.0 mL. Drug Reconstitution System - The needle-free drug reconstitution system allows for the transfer of diluents to reconstitute powdered medications into liquid form and withdrawal of liquid medication into a syringe without the use of a needle. Vitajet - The Vitajet is also composed of two components, a portable injector unit and a disposable syringe. It is smaller and lower in cost than other products in its needle-free offering. ZetaJet - The ZetaJet is Biojects latest advance in needle-free delivery systems. It consists of two components, the portable injector and an auto-disabling disposable syringe. The medical equipment market is very competitive. Bioject Medical Technologies has two patents: Biojector 2000 and Vitajet. The Companys products and manufacturing operations are subject to extensive government regulations, both in the U.S. and abroad. In the U.S., the Food and Drug Administration (FDA) administers the Federal Food, Drug and Cosmetic Act (FFDCA) and has adopted regulations to administer the FFDCA.
Executives
James C Gale director 152 W 57TH STREET, 19TH FLOOR, NEW YORK NY 10019
Sanders Morris Harris Inc/fa 10 percent owner, other: See General Remarks 600 TRAVIS, SUITE 5900, HOUSTON TX 77002
David S Tierney director C/O ABLE LABORATORIES, INC., 6 HOLLYWOOD COURT, CN 1013, SOUTH PLAINFIELD NJ 07080
Edward L Flynn director, 10 percent owner 211 SOMERVILLE ROAD RTE 202N, BEDMINISTER NJ 07921
Life Sciences Opportunities Fund Ii Lp 10 percent owner 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Lof Partners Llc other: See general remarks 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Life Sciences Opportunities Fund Instittutional Ii Lp 10 percent owner 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Randal D Chase director 28 GEORGIA COURT, RICHMOND HILL A6 L4E ON7
Brigid Makes director 20245 SW 95TH AVENUE, TUALATIN OR 97062
J Michael Redmond officer: Sr. VP Bus Dev. 10 CANTERBURY ROAD, WINDHAM NH 03087
Elan Corp Plc 10 percent owner TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN 2 L2 00000
Elan International Services Ltd 10 percent owner C/O TREASURY BUILDING, LOWER GRAND CANAL STREET, DUBLIN L2 2
Elan Pharmaceutical Investments Ltd 10 percent owner 102 ST JAMES COURT, FIETSS SMITH FL BERM D0 9999999999
John P Gandolfo officer: CFO 62 TERRACE ROAD, WAYNE NJ 07470
Grace K Fey director 1210 CROMWELL ROAD, HALIFAX NOVA SCOTIA A5 B3H4L2

Bioject Medical Technologies (Bioject Medical Technologies) Headlines

No Headlines